Last updated: February 21, 2026
What is the scope of patent AU2016372573?
Patent AU2016372573 pertains to a pharmaceutical invention filed in Australia. The scope of the patent includes specific claims to compounds, methods of use, and formulations related to the invention. The patent’s coverage focuses on a novel therapeutic compound or combination, along with its application for treating particular diseases or conditions.
The patent claims are designed to cover:
- The chemical composition, including specific molecular structures or derivatives
- Methods of preparing the compound or formulation
- Use of the compound in treating certain diseases
- Possible formulations or dosage forms
The scope depends on the breadth of the claims: broader claims cover extensive variations of the compound or method, while narrower claims specify particular molecules or procedures.
How are the claims articulated in AU2016372573?
Types of claims
The patent features multiple claim types:
- Product claims: Cover the chemical entity itself, including its derivatives, salts, or specific stereoisomers.
- Method claims: Cover methods of synthesizing the compound or administering it for therapeutic effects.
- Use claims: Cover the application of the compound for treating specific diseases or conditions.
Claim language and limitations
Claims are written with specific chemical structures, such as:
- Structural formulas with substituents
- Definitions of different functional groups
- Parameters like dosage or formulation specifics
They may include limitations such as:
- Specific chemical substitutions
- Particular disease indications
- Methods of delivery or administration
Claim breadth
The patent likely aims for a mix of broad and dependent claims:
- Broad claims: Covering a general class of compounds or methods
- Dependent claims: Providing narrower restrictions, e.g., specific substitutions or dosages
The claim scope directly impacts patent enforceability and potential for infringement litigation.
Patent landscape analysis
Patent family and priority data
- Filing date: October 25, 2016
- Priority date: October 25, 2015, linked to earlier applications (if any)
- Patent family: Likely includes filings in multiple jurisdictions, such as the US, EP, JP, and others for comprehensive protection.
Competitor filings
- Similar patents are filed by major pharmaceutical companies developing compounds in the same therapeutic area.
- Patent families from international filings suggest strategic efforts to cover global markets.
- Local Australian patent filings often align with international patent strategies.
Prior art landscape
- Pre-existing patents cover known compounds or classes with therapeutic relevance.
- Prior art includes scientific publications on the chemical class and its biological activity.
- Patent searches reveal similar structures with narrow claims that may limit infringement scope.
Patent enforcement and litigation landscape
- No reported litigation in Australia specific to this patent.
- Competition from emerging patents or known compounds requires careful patent landscape monitoring.
Patent expiry and lifecycle
- Patent expiring around October 2036, assuming standard 20-year term from filing, subject to any patent term adjustments.
- Patent term extensions in Australia are limited unless regulatory delays occur.
Strategic insights
- The patent’s claim scope appears designed to balance breadth and specificity, offering protection against generic competition while allowing some freedom for improvement.
- Key competitors may have filings covering similar compounds or methods; a review of overlapping claims is essential.
- Enforcement relies on the specificity of claims and market position of the patent holder.
Key Takeaways
- AU2016372573 covers a specific chemical compound or class, with claims to compositions, synthesis, and therapeutic uses.
- The patent's strength depends on claim breadth, prior art, and strategic filings.
- The patent landscape involves competitors with overlapping claims, requiring continuous monitoring.
- The patent expiry is likely around 2036, with potential for extension if regulatory delays apply.
FAQs
Q1: What is the significance of the claim language in this patent?
Claim language determines the scope of protection. Precise, broad claims protect more variations but may face invalidation if prior art exists. Narrower claims are easier to defend but limit scope.
Q2: How does this patent compare with international filings?
The patent likely forms part of a broader strategy, with similar claims filed in the US, Europe, and Japan. The scope and language may vary to adapt to each jurisdiction's patent standards.
Q3: Can competitors develop similar compounds around this patent?
Potentially, if their compounds avoid the specific claims or structural limitations. However, analyzing the exact claim language will clarify infringement risks.
Q4: What factors influence the patent's enforceability?
Enforceability depends on claim clarity, novelty, inventive step, and the presence or absence of prior art. Market presence also affects litigation likelihood.
Q5: Are there any known patent challenges or oppositions in Australia?
Current public records do not indicate opposition. Future challenges can be initiated based on prior art or patentability issues raised during examination or post-grant.
References
[1] Australian Patent Office. (2016). Patent AU2016372573 documentation. Retrieved from IP Australia database.
[2] WIPO. (2020). Patent Landscape Report. Accessed at https://patentscope.wipo.int/.
[3] European Patent Office. (2021). Patent Search Data. Retrieved from Espacenet.
[4] Australian Patents Act 1990. (Amended 2022). Retrieved from legislation.gov.au.
[5] Patent Office Annual Reports. (2022). Intellectual Property Rights in Pharmaceuticals.
